401 Current news from the ressort cooperation
rss01-25-2012
Sartorius Stedim Biotech (SSB) and Refine Technology (Refine) will be collaborating on the development of a robust platform for high-density cell cultivation. This platform will enable fast, easy connection of the ATF System to SSB’s single-use BIOSTAT® bioreactors.This joint development ...
01-24-2012
Agilent Technologies Inc. and Integrated Diagnostics announced a strategic partnership to develop assays that detect major human diseases at very early stages to improve treatment outcomes. Officials of both organizations see an opportunity to rapidly turn medical breakthroughs into ...
01-11-2012
QIAGEN N.V. and the Max Planck Institute for Infection Biology (MPIIB), Department of Immunology have announced a new collaboration to develop a molecular diagnostic test to assess the risk of an individual with latent tuberculosis (TB) developing active TB disease during their lifetime. ...
Companies Combine Expertise to Advance Biomarkers for the Early Diagnosis of Pancreatic Cancer
11-09-2011
Oxford Gene Technology (OGT) has announced a collaborative agreement with Abcodia aimed at improving the early detection of pancreatic cancer. As part of this collaboration, Abcodia will provide access to its large prospective serum biobank, to harness samples taken from individuals up to 7 ...
11-02-2011
Protagen AG and Charles River Laboratories International, Inc. are announce a strategic Marketing & Sales alliance. For Charles River Biopharmaceutical Services (BPS) the fast-growing demand for biopharmaceuticals testing requires an expert partner with a broad range of services. Charles ...
10-24-2011
Agilent Technologies Inc. and the University of Technology, Sydney, announced the establishment of a joint nuclear magnetic resonance research facility. “At UTS, we’re already doing some fantastic work using NMR, including a project looking at the development of more effective fingerprinting ...
10-07-2011
Epistem announced the formation of a human DNA Identification collaboration with the National Policing Improvement Agency (NPIA). Epistem and the NPIA will be evaluating Epistem’s Genedrive™ molecular device as part of the NPIA’s ADAPT programme (Accelerated DNA Profiling Technology ...
09-19-2011
Abnova Corporation and Clearbridge BioMedics announced a collaboration to jointly develop a platform that provides a next generation, non-invasive “liquid biopsy” for cancer screening, staging, treatment, and monitoring. Through this collaboration, Abnova will leverage upon Clearbridge ...
08-16-2011
Sequenom, Inc. announced it has partnered with LifeCodexx AG for the commercialization of prenatal laboratory testing services in Europe. The companies have agreed to collaborate in the development and launch of a trisomy 21 laboratory developed test and other aneuploidies testing in Germany, ...
08-11-2011
Axel Semrau and ThalesNano announced the signing of a collaboration agreement for product distribution in the territory of Germany. “We are very proud and excited about partnering with Axel Semrau. is a leading distributor for analytical instruments in Germany - said Dr. Ferenc Darvas, ...
